Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

MPN - 161

Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Targeting Metabolic-Inflammatory Signaling in Chronic Myelomonocytic Leukemia: Association of GLP-1 Receptor Agonist Therapy with Improved Real-World Outcomes

MPN - 1634

Targeting Metabolic-Inflammatory Signaling in Chronic Myelomonocytic Leukemia: Association of GLP-1 Receptor Agonist Therapy with Improved Real-World Outcomes

Asfand Yar Cheema

Poster Presenter: Asfand Yar Cheema

Thumbnail for Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Chronic Myelomonocytic Leukemia: A SEER-Based Analysis

MPN - 1641

Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Chronic Myelomonocytic Leukemia: A SEER-Based Analysis

Mishaal Munir

Poster Presenter: Mishaal Munir

Thumbnail for KIT D816V-Selective Tyrosine Kinase Inhibitors for the Treatment of Advanced Systemic Mastocytosis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes

MPN - 1664

KIT D816V-Selective Tyrosine Kinase Inhibitors for the Treatment of Advanced Systemic Mastocytosis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes

Abdullah Ali

Poster Presenter: Abdullah Ali

Thumbnail for Hypocellular Bone Marrow as an Independent Adverse Prognostic Feature in Primary Myelofibrosis: A Real-World Analysis of 241 Patients

MPN - 1673

Hypocellular Bone Marrow as an Independent Adverse Prognostic Feature in Primary Myelofibrosis: A Real-World Analysis of 241 Patients

Elmir Guluyev

Poster Presenter: Elmir Guluyev

Thumbnail for Luspatercept for Anemia in Myelofibrosis: A Systematic Evidence Synthesis and Random-Effects Meta-Analysis

MPN - 1675

Luspatercept for Anemia in Myelofibrosis: A Systematic Evidence Synthesis and Random-Effects Meta-Analysis

Arafat Shabbir

Poster Presenter: Arafat Shabbir

Thumbnail for Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis

MPN - 1689

Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis

Nneoma Ubah

Poster Presenter: Nneoma Ubah

Thumbnail for Ropeginterferon Alfa-2b vs Hydroxyurea in Polycythemia Vera: A Propensity Score-Matched Real-World Analysis of Thrombotic Events and Phlebotomy Burden

MPN - 1691

Ropeginterferon Alfa-2b vs Hydroxyurea in Polycythemia Vera: A Propensity Score-Matched Real-World Analysis of Thrombotic Events and Phlebotomy Burden

Vedant Shah

Poster Presenter: Vedant Shah

Thumbnail for Projected Healthcare Resource Use and Budget Impact of Once-Daily Extended-Release vs Twice-Daily Immediate-Release Ruxolitinib in Myelofibrosis

MPN - 204

Projected Healthcare Resource Use and Budget Impact of Once-Daily Extended-Release vs Twice-Daily Immediate-Release Ruxolitinib in Myelofibrosis

Sumit Verma

Poster Presenter: Sumit Verma